IMW 2019: The New GSK Antibody Drug Conjugate in Myeloma
Oct 02, 2019
An antibody drug conjugate is a type of immunotherapy being explored in multiple myeloma. Glaxo-Smith Klein is developing a new...
Oct 15, 2019
LIFE WITH MYELOMA
Oct 07, 2019
Earlier detection of multiple myeloma before bone damage...
MUSCLES FOR MYELOMA
Muscles for Myeloma: Living a Normal Life
Oct 02, 2019
September was Blood Cancer Awareness month and time to focus on how some myeloma patients are developing Muscles for Myeloma. Staying fit is critical for your best myeloma outcomes. Every patient will be different in what they can do, so talk with...
IMW 2019: A Vaccine to Extend Myeloma Remissions with Syed Abbas Ali, MD
Sep 19, 2019
When should myeloma vaccines be used for patients? Dr. Syed Abbas Ali, MD of Johns Hopkins Medicine tells us that it’s usually when there is a low tumor burden, like after stem cell transplant or when patients are on maintenance and...
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
MYELOMA CROWD RESEARCH INITIATIVE
The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.Learn More >
Thanks to our site sponsors: